Dare Bioscience, Inc.
For the period ended Dec 31, 2025. Filed Mar 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 26, 2026
DARE$0.68+6.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements and Supplementary Data
Our consolidated financial statements required to be included in this Item 8 are set forth in a separate section of this report commencing on page F-1.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.